Plain-English translation of NCT07271043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether drinking high-protein shakes designed specifically for people with type 2 diabetes can help preserve lean muscle mass while you lose weight. You'll be compared to people receiving standard diabetes care to see if the shakes make a real difference. The study focuses on people who are just starting treatment with medications like semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), or dulaglutide (Trulicity®).
When people take these newer diabetes medications, they often lose weight — which is good — but they can also lose muscle, which isn't ideal. This trial is testing whether adding a specially designed high-protein shake can help you keep your muscle mass while still getting the weight-loss benefits of the medication.
You likely qualify if…
You likely don't qualify if…
If you join, you'll either drink two high-protein shakes per day as part of your routine, or you'll receive standard diabetes care without the shakes (assigned randomly). Either way, you'll continue taking your diabetes medication as planned. The study will track changes in your muscle mass and body composition over time through measurements and possibly other assessments at clinic visits.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States